Tilray Launches New Medical Cannabis Edibles in Canada
August 05 2021 - 7:00AM
Business Wire
New Product Innovations Respond to Patient
Needs Across Medical Category
Tilray, Inc. (“Tilray”) (Nasdaq I TSX: TLRY), a global pioneer
in medical cannabis research, cultivation, and production, today
announced the launch of medical cannabis edibles in THC and
CBD-rich varieties of chocolates and soft chew gummies. The new
Tilray-branded medical cannabis edibles are now available for
patients across Canada and add to the brand’s comprehensive
offering of cannabis medicines, including whole flower, oils,
vapes, and pre-rolls developed with patient health and wellbeing in
mind.
Irwin D. Simon, Tilray’s Chairman and Chief Executive Officer,
said, “Whether it’s pain management, anxiety treatment, or
everything in between, patients are asking for more choices in the
medical cannabis category, and Tilray remains committed to the
innovations that improve patient wellbeing. As cannabis regulations
evolve around the world, we look forward to offering our global
patient community the highest-quality medicines they depend on for
health, wellness and wellbeing.”
Tilray’s new medical cannabis edibles include two formulations
of 16-gram medical cannabis-infused chocolate bars in THC Milk
Chocolate containing 10mg of THC and <1mg of CBD per package and
CBD Dark Chocolate containing 1mg of THC and 20mg of CBD per
package, as well as two formulations of medical cannabis soft chews
available in Watermelon containing 10mg of THC and Pineapple-Mango
containing 10mg of THC and 10mg of CBD.
Jim Meiers, President at Tilray Canada, said, “Tilray continues
to deliver the benefits of cannabis safely and reliably in unique
formats that suit patients’ needs. Our goal is to help provide
patients access to the highest-quality medical cannabis products
that can improve their quality of life, and also support them with
best-in-class service and programs so they make the choices best
suited to their needs.”
For more information about Tilray medical cannabis products,
visit: www.Tilray.ca
About Tilray Inc.
Tilray, Inc. is a leading global cannabis-lifestyle and consumer
packaged goods company with operations in Canada, the United
States, Europe, Australia, and Latin America that is changing
people’s lives for the better – one person at a time – by inspiring
and empowering the worldwide community to live their very best life
by providing them with products that meet the needs of their mind,
body, and soul and invoke a sense of wellbeing. Tilray’s mission is
to be the trusted partner for its patients and consumers by
providing them with a cultivated experience and health and
wellbeing through high-quality, differentiated brands and
innovative products. A pioneer in cannabis research, cultivation,
and distribution, Tilray’s unprecedented production platform
supports over 20 brands in over 20 countries, including
comprehensive cannabis offerings, hemp-based foods, and alcoholic
beverages.
For more information about Tilray, Inc., visit:
www.Tilray.com
Forward-Looking Statements
Certain statements in this communication that are not historical
facts constitute forward-looking information or forward-looking
statements (together, “forward-looking statements”) under Canadian
securities laws and within the meaning of Section 27A of the
Securities Act of 1933, as amended, and Section 21E of the
Securities Exchange Act of 1934, as amended, that are intended to
be subject to the “safe harbor” created by those sections and other
applicable laws. Forward-looking statements can be identified by
words such as “forecast,” “future,” “should,” “could,” “enable,”
“potential,” “contemplate,” “believe,” “anticipate,” “estimate,”
“plan,” “expect,” “intend,” “may,” “project,” “will,” “would” and
the negative of these terms or similar expressions, although not
all forward-looking statements contain these identifying words.
Certain material factors, estimates, goals, projections or
assumptions were used in drawing the conclusions contained in the
forward-looking statements throughout this communication. Many
factors could cause actual results, performance or achievement to
be materially different from any forward-looking statements, and
other risks and uncertainties not presently known to the Company or
that the Company deems immaterial could also cause actual results
or events to differ materially from those expressed in the
forward-looking statements contained herein. For a more detailed
discussion of these risks and other factors, see the most recently
filed annual information form of Aphria and the Annual Report on
Form 10-K (and other periodic reports filed with the SEC) of Tilray
made with applicable securities regulatory authorities and
available on SEDAR and EDGAR. The forward-looking statements
included in this communication are made as of the date of this
communication and the Company does not undertake any obligation to
publicly update such forward-looking statements to reflect new
information, subsequent events or otherwise unless required by
applicable securities laws.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20210805005187/en/
For media inquiries, please contact: Berrin Noorata
news@tilray.com For investor inquiries, please contact:
Raphael Gross 203-682-8253 Raphael.Gross@icrinc.com
Tilray Brands (NASDAQ:TLRY)
Historical Stock Chart
From Mar 2024 to Apr 2024
Tilray Brands (NASDAQ:TLRY)
Historical Stock Chart
From Apr 2023 to Apr 2024